Channel
@AVICENNA_MEDICINE
On this record: Topic · Growth · Engagement · What this channel posts · Reactions · Posts · Citations · Cite this entry
17subscribers
-1 since we began measuring on 7 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
| Telegram ID | -1001808647819 |
|---|---|
| Type | Channel |
| Username | @AVICENNA_MEDICINE |
| Created | Between 1 October 2022 and 30 September 2023 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 11 August 2026 |
| Last confirmed live | 6 October 2026 |
| Measurements held | 3 |
| Confirmed unchanged | 5 times, most recently 6 October 2026 |
| On Telegram | t.me/AVICENNA_MEDICINE |
Other / unclassifiable — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 1 October 2026 and assigned it the closest of 31 fixed categories, at 75% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 27 Aug 2026, 23:03 | 17 | -1 |
| 11 Aug 2026, 18:15 | 18 | no change |
| 7 Aug 2026, 10:58 | 18 | first reading |
20 posts held, back to 2 December 2023 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 20 posts for this entry, the most recent from 16 January 2026. An engagement rate over an empty window would be a number about nothing.
Measured directly from 8 videos with a duration reading, out of the posts we hold for this channel — not this channel’s whole posting history, only the sample this register has actually read. An exact reading to the second, taken from the post itself rather than from Telegram’s own rounded chrome, so it carries no ≈ mark.
29 reactions across 14 posts, in 6 distinct kinds. The most used accounts for 72.4% of them.
| Reaction | Count | Share | Share, drawn |
|---|---|---|---|
| 👍 | 21 | 72.4% | |
| 🥰 | 3 | 10.3% | |
| ❤ | 2 | 6.90% | |
| 💯 | 1 | 3.45% | |
| 😐 | 1 | 3.45% | |
| 😢 | 1 | 3.45% |
No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.
Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.
Coverage. Reactions were read on 15 of the 20 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 29 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.
Measured over the 20 most recent posts we hold, published 2 December 2023 to 16 January 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.
The owner of this channel has been inactive for the last 11 months. If they remain inactive for the next 8 days, they may lose their account and admin rights in this channel. The contents of the channel will remain accessible for all users.
Tarqaladigan!
😢1
Рад был помочь! Ваш, @SaveAsBot
👍1
Рад был помочь! Ваш, @SaveAsBot
😐1
Telefonni zaryadkada turganda ham foydalanadigan, muborak kallalarini ishlatadigan yaqinlarimizga yuborib qo'yamiz.☺️ https://t.me/AVICENNA_MEDICINE
👍1
BISSMILLAH # 🔴 DIQQAT ESLATMA ! SAXARLIK VAQTI SHIRINLIK VA CHAQ CHUQLAR YEMEYLA KUN BO'YI CHANQATADI . VA QONDA SHAKARILANI KO'PAYTIRIB,QONNI YOPISHQOQ QIlIB VUJUDIYLANI SUVSIZLANTIRIB QURUQLIK XOSIL QILADI. @TIBUNNABAVI
👍5
Зарарли овқат қўшимчалари Таркибида қуйидаги озуқавий қўшимча моддалар мавжуд бўлган маҳсулотларни имкон қадар истеъмол қилманг, улар саломатлик учун хавфлидир! E621 — Натрий Глютамат Таъм кучайтиргич сифатида ишлатиладиган озуқавий қўшимчадир. Сотиб олмоқчи бўлган озиқ-овқат маҳсулотингиз қадоғида таркибини ўқинг. Агар маҳсулот таркибида Натрий Глютамат бўлса сотиб олмаганингиз маъқул. "Шакар ўрнини босувчилар" Б…
TABIB KIM? Tabib - inson organizimida kamayib ketishi zarar bo'lgan narsalarni ko'paytirib beruvchi, ko'payib ketishi zarar bo'lgan narsalarni kamaytirib beruvchi ilm soxibidir. Masalan : Inson organizimida qon, immunitet, vitamin va garmonlar ishlab chiqarilishi kamayib ketsa inson salomatligi buzilishi hammaga ma'lum. Ko'payib ketishi zarar bo'lgan narsalarga ham yuqoridagi elementlar kiradi. Tabiybning ishi o'…
👍4
Video, posted without a caption
Video, posted without a caption
🩸🦠🧬💉KASALLIKLARGA OSSON YECHIM... Abu Hurayra roziyaallohu anhu, Paygʻambarimiz Muhammad sollallohu alayhi vasallamdan rivoyat qilingan hadisi qudsiyda Alloh Azza va Jalla aytadi: “Men bandamning gumonidaman!,, Banda yaxshilikni gumon qilsa, yaxshilikni koʻradi, yomonlikni gumon qilsa, yomonlikni koʻradi”. (Buxoriy va Muslim rivoyati). Kasallik ikki xil sababdan keladi vallohi a'lam! 1. Yo Allohni raxmati bo'lib! …
👍2
Muolajaning afzali! 1. Tavba terapiya 2.Shukur terapiya 3. Alloh bilan orasini isloh qilish! 4. Insonlar bilan orasini isloh qilish (Kimnidir qalbini og'ritgan xaqqiga kirgan , norizo qilgan bo'lsa rozi qilish! 5. Qur'on va Sunnatda taqiqlangan odatlar tark etish! 6.To'g'ri va tartibli mo'tadil yashash va sodda yeb ichish! Shundan so'nggina inson sog'lom fikirlashni boshlaydi! Sog'lom fikirga ega insonni jasadi ha…
👍1
Showing the 12 most recent of 20 posts we hold for @AVICENNA_MEDICINE. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Names
Channels on the register whose handles appear in this channel's posts.
A mention is a weaker signal than a forward and is counted separately for that reason — naming a channel is not republishing it, and a handle in a post body is easy to place deliberately. The post counts beside each row below are distinct posts in which the handle appeared, from posts we have read on both sides — the “Named by N registered channels” figure above is a different count, of distinct NAMING CHANNELS rather than posts, and is not the sum of the rows under it.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 27 August 2026 — this entry's latest reading, not the date you are reading this.
“Xodiyjah_school | Avicenna_Medicine asosida” (@AVICENNA_MEDICINE), 17 subscribers as measured 27 August 2026. Telegram Register, tgregister.com/channel/AVICENNA_MEDICINE.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.